|
C19ORF24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13519999999745E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.428000E-04 |
| Normal-vs-Stage2 |
3.964300E-03 |
| Normal-vs-Stage3 |
3.427400E-04 |
| Normal-vs-Stage4 |
2.518800E-03 |
| Stage1-vs-Stage2 |
1.437050E-01 |
| Stage1-vs-Stage3 |
2.118000E-01 |
| Stage1-vs-Stage4 |
8.496000E-01 |
| Stage2-vs-Stage3 |
4.830800E-01 |
| Stage2-vs-Stage4 |
1.901220E-01 |
| Stage3-vs-Stage4 |
3.453000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.24959999999675E-05 |
| Normal-vs-AfricanAmerican |
9.503600E-02 |
| Normal-vs-Asian |
1.083170E-03 |
| Caucasian-vs-AfricanAmerican |
4.939000E-01 |
| Caucasian-vs-Asian |
6.279400E-01 |
| AfricanAmerican-vs-Asian |
3.010400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.245270E-04 |
| Normal-vs-Female |
5.71069999999452E-05 |
| Male-vs-Female |
9.401800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.197330E-03 |
| Normal-vs-Age(41-60Yrs) |
5.56619999999564E-05 |
| Normal-vs-Age(61-80Yrs) |
2.039100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.970500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.178000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.263600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.534400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.727600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.385400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.844400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.188800E-01 |
| Classical-VS-Follicular |
1.185040E-01 |
| Classical-VS-Other |
7.280800E-01 |
| Classical-VS-Normal |
6.399300E-04 |
| Tall-VS-Follicular |
7.802600E-01 |
| Tall-VS-Other |
5.285400E-01 |
| Tall-VS-Normal |
9.925900E-02 |
| Follicular-VS-Other |
4.010800E-01 |
| Follicular-VS-Normal |
9.56020000000279E-05 |
| Other-VS-Normal |
3.070800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.27580000026151E-07 |
| Normal-vs-N1 |
1.943910E-02 |
| N0-vs-N1 |
4.924600E-01 |
|
|
